diapos resolucion essalud 2006
DESCRIPTION
KTRANSCRIPT
![Page 1: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/1.jpg)
EXÁMEN PREINTERNADO
ESSALUD 2006
Asegura Tu Ingreso!!!
![Page 2: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/2.jpg)
![Page 3: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/3.jpg)
![Page 4: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/4.jpg)
![Page 5: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/5.jpg)
Tests ResultsInterpretati
onHBsAg negative
Susceptibleanti-HBc negative
anti-HBs negative
HBsAg negative Immune due to natural
infectionanti-HBc positive
anti-HBs positive
HBsAg negative Immune due to hepatitis B
vaccination*anti-HBc negative
anti-HBs positive
HBsAg positive
Acutely infectedanti-HBc positive
IgM anti-HBc positive
anti-HBs negative
HBsAg positive
Chronically infected
anti-HBc positive
IgM anti-HBc negative
anti-HBs negative
HBsAg negative Four interpretations
possible•anti-HBc positive
anti-HBs negative
* Antibody response (anti-HBs) can be measured
quantitatively or qualitatively. A protective antibodyresponse is reported quantitatively as 10 or more milliinternational units (>=10 mIU/mL) or qualitatively
as positive. Post-vaccination testing should be completed 1-2 months after the third vaccine dose
for results to be meaningful.• Four Interpretations:1. Might be recoveringfrom acute HBV infection.
2. Might be distantly immune and test notsensitive enough to detect very low level of anti-
HBs in serum.3. Might be susceptible with a false positive anti-HBc.
4. Might be undetectable level of HBsAg presentin the serum and the personis actually
chronically infected
![Page 6: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/6.jpg)
![Page 7: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/7.jpg)
![Page 8: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/8.jpg)
![Page 9: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/9.jpg)
![Page 10: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/10.jpg)
![Page 11: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/11.jpg)
OBSTETRICIA [email protected]
Agudo – crónico. Masivo -submasivo. FR EXCLUSIVOS: inmovilización, cirugia <3m, ECV, paresia, paralisis, TVP, cáncer, CVC <3m, ICC. Obesas, fumadoras pesadas e hipertensas.
•No es útil. Asintomáticos 32%. •Disnea subita, dolor pleural, tos, ortopnea, dolor pierna, edema pierna, sibilantes. Tq, Tf, rales, bajo MV, 2RC, IY.
• Clínica de edema agudo pulmón.
• Signos y síntomas de TEP.• Clínica de embolismo graso.
EDEMA AGUDO
PULMONAR DE ALTURA Y TEP
• Reanimacion:• Soporte hemodinámico: norepinefrina, dopamina,
dobutamina?.• Anticoagulacion:
• INICIACION • ELECCION DE FARMACO (HBPM, HNF, fondaparinux,
warfarina, dabigatran) • COMPLICACIONES • DURACION DE TERAPIA (primer episodio: FR
identificable y reversible)(TEP recurrente)• Trombolisis. - Filtros de la VC inferior. - Embolectomia. • Tto ambulatorio.• Tto expectante.
![Page 12: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/12.jpg)
OBSTETRICIA [email protected]
![Page 13: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/13.jpg)
OBSTETRICIA [email protected]
![Page 14: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/14.jpg)
VULVOVAGINITIS
www.qxmedic.com – qxmedic.gmail.com – 989233799 – 986810597
CANDIDA TRICOMONA GARDENELLA
Frecuencia La + sintomatica La menos frec La más frec
F Riesgo Estrogenos, DM,
VIH, ATB, CC
ETS siempre NO ETS:
gestación, DIU
Sintoma ppal Prurito!!! Leucorea Asintomática
Leucorrea Blanquecino y grumoso Espumoso y con
burbujas
Gris y maloliente
Exploración Eritema Colpitis en fresa Normal
pH vagina <4,5 >4,5 >4,5
Microscopia salino Esporas Tricomonas Clue cels>20%
Diagnóstico Cultivo Saboureaud Examen en fresco Prueba de aminas +
Tratamiento Clotrimazol topico Metronidazol vo + tto
pareja
Metronidazol o
clindamicina vo/topico
![Page 15: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/15.jpg)
http://www.midis.gob.pe/dgsye/data1/files/enic/eje2/estudio-investigacion/NT_CRED_MINSA2011.pdf
![Page 16: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/16.jpg)
![Page 17: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/17.jpg)
www.qxmedic.com – qxmedic.gmail.com – 989233799 – 986810597
TOCOLÍTICOS
![Page 18: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/18.jpg)
Histology Number of patients Incidence
Squamous cell 627 83.4
Adenocarcinoma 70 9.3
Sarcoma 20 2.6
Melanoma 2 2.6
Undifferentiated 8 1.0
Small cell 5 0.7
Lymphoma 2 0.3
Carcinoid 1 0.1
Total 753 100.0
www.qxmedic.com – qxmedic.gmail.com – 989233799 – 986810597
CÁNCER DE VAGINA
![Page 19: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/19.jpg)
INTRODUCTION — Syphilis is a systemic infection caused by the spirochete Treponemapallidum, which is of particular concern during pregnancy because of the risk of transplacental infection of the fetus. Congenital infection is associated with several adverse outcomes [1-5], including:•Perinatal death•Premature delivery•Low birth weight•Congenital anomalies•Active congenital syphilisin the neonate•Long-term sequelae,such as deafness and neurologic impairment
www.qxmedic.com – qxmedic.gmail.com – 989233799 – 986810597
SIFILIS GESTANTE
![Page 20: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/20.jpg)
![Page 21: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/21.jpg)
![Page 22: Diapos Resolucion ESSALUD 2006](https://reader033.vdocuments.mx/reader033/viewer/2022052404/577c86591a28abe054c0caa1/html5/thumbnails/22.jpg)
www.qxmedic.com – qxmedic.gmail.com – 989233799 – 986810597